MOSCOW (Reuters) – Russia’s sovereign wealth fund RDIF said on Thursday that it had agreed to manufacture Russia’s first registered COVID-19 vaccine “Sputnik-V” in Brazil.
RDIF, which is backing the vaccine’s development, also said it planned to supply up to 100 million doses of the vaccine to Latin America.
(Reporting by Polina Ivanova; Writing by Maria Kiselyova; Editing by Hugh Lawson)
